Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
Ciro Indolfi,
Salvatore De Rosa,
Annalisa Mongiardo,
Carmen Spaccarotella,
Jolanda Sabatino,
Isabella Leo,
Antonio Strangio,
Sabrina La Bella,
Sabato Sorrentino,
Alberto Polimeni
Affiliations
Ciro Indolfi
Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy
Salvatore De Rosa
Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy
Annalisa Mongiardo
Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy
Carmen Spaccarotella
Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy
Jolanda Sabatino
Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy
Isabella Leo
Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy
Antonio Strangio
Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy
Sabrina La Bella
Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy
Sabato Sorrentino
Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy
Alberto Polimeni
Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy
Aims To investigate the changes in left atrial strain (LAS) after correction of severe aortic stenosis (AS) with transcatheter aortic valve replacement (TAVR) and assess its prognostic impact.Methods and results One hundred consecutive patients with severe symptomatic AS who underwent TAVR at the Magna Graecia University of Catanzaro underwent echocardiographic examination including assessment of LAS before and after TAVR. Independent investigators collected outcome data and information. The primary study outcome was the difference in ΔLAS (postTAVR–preTAVR) between patients those met the main clinical endpoint (a composite of cardiovascular mortality and heart failure hospitalisation) and those not meeting the endpoint.During a median follow-up of 31 months, 35 patients (35%) met the combined clinical endpoint. The difference between LAS post-TAVR and LAS pre-TAVR (ΔLAS) was significantly larger in patients who met the combined endpoint (HR=0.76 (0.67–0.86); p<0.001). Multivariate logistic regression analysis including ΔLAS, EuroSCORE II and left ventricular ejection fraction showed that ΔLAS (HR=0.80, p<0.001) was the only independent predictor of the combined clinical endpoint. Finally, a Kaplan-Maier analysis showed that patients with a ΔLAS above its median value had a significantly better event-free survival compared with those below the median (p<0.001).Conclusions A lower reduction in ΔLAS after TAVR was an independent predictor of the primary composite outcome of cardiovascular death and hospitalisation for heart failure.